background: DDX3Y (DBY), located within AZoospermia Factor a (AZFa) region of the human Y chromosome (Yq11), encodes a conserved DEAD-box RNA helicase expressed only in germ cells and with a putative function at G1-S phase of the cell cycle. Deletion of AZFa results most often in germ cell aplasia, i.e. Sertoli-cell-only syndrome. To investigate the function of DDX3Y during human spermatogenesis, we examined its expression during development and maturation of the testis and in several types of testicular germ cell tumours (TGCTs), including the pre-invasive carcinoma in situ (CIS) precursor cells which are believed to originate from fetal gonocytes.
Introduction
DDX3 genes appeared on the sex chromosomes of mammals 130 million years ago as part of an autosomal translocation process (Marshall Graves, 2006 ). Chromosome-specific rearrangements then located DDX3X and DDX3Y in the non-recombining part of both sex chromosomes (Lahn and Page, 1999) . Subsequently, a separate evolution of their functional gene structures was observed in the mouse and primates (Rauschendorf et al., 2011) . In human adults, it resulted in restriction of DDX3Y protein expression to only premeiotic male germ cells, whereas the DDX3X protein is expressed in post-meiotic spermatids and in multiple somatic tissues (Ditton et al., 2004) . Nevertheless, DDX3X and DDX3Y retained their functional homology, as demonstrated by their exchangeable control of the G1-S phase at the cell cycle of BHK21 hamster cells (Sekiguchi et al., 2004) and their equal ability to rescue the translational initiation control factor in yeast cells, which lack the Ded1p protein ortholog (Chuang et al., 1997) .
In human male germ cells, DDX3Y protein production is under strict quantitative control, which is exerted by the translational repressor effects of distinct DDX3Y transcript variants with long 5 ′ -untranslated regions (UTRs; Jaroszynski et al., 2011) . Similar long and complex 5 ′ UTRs have been found in transcripts of oncogenes and of other genes functioning in control of the cell cycle (Kozak, 2002) . These genes transcripts need a tight quantitative translation control because the proteins are required only at specific cellular phases. The DDX3 protein controls the translation initiation of cyclin E1, which is needed for cell cycle progression from the G1 to S phase (Lai et al., 2010) . Cyclin E1 over-expression results in tumour development (Hwang and Clurman, 2005) . Since the human DDX3Y protein is only expressed in spermatogonia (Ditton et al., 2004) , we assume that it is functionally involved in control of their pre-meiotic proliferation rate. We hypothesize, therefore, that its over-expression may play a role in male germ cell malignancy, similarly to that found for DDX3X, e.g. during development of breast cancer (Botlagunta et al., 2008) .
The development of male germ cell malignancy usually starts from the so-called carcinoma in situ (CIS) germ cells (Skakkebaek et al., 1987) , also known as the intratubular germ cell neoplasia unclassified (ITGCNU; Ulbright, 1993) . CIS is the pre-invasive precursor of the two most common types of testicular germ cell tumours (TGCTs): the morphologically homogeneous seminoma and the heterogeneous non-seminoma (Skakkebaek et al., 1987; Ulbright, 1993 , Looijenga, 2009 . TGCTs are observed most frequently in young adults between 15 and 44 years (McGlynn and Cook, 2009 ). Additionally, a distinct but rare TGCT type, called spermatocytic seminoma, occurs in older men. Spermatocytic seminoma is not preceded by CIS; instead the pre-meiotic spermatogonia are the most likely cells of origin (Rajpert-De Meyts et al., 2003a; Lim et al., 2011) . Experimental evidence suggests that CIS cells originate from immature fetal germ cells, called gonocytes that failed to mature to adult spermatogonia and retained high expression of embryonic pluripotency factors (Jørgensen et al., 1995; Almstrup et al., 2004; Honecker et al., 2004; Rajpert-De Meyts, 2006; Sonne et al., 2009) . Interestingly, only after puberty do CIS cells progress toward invasive tumour cells.
The expression of DDX3Y has not yet been studied during human testis development. Following our previous study where we revealed germ cell-specific expression of the DDX3Y protein in the adult testis (Ditton et al., 2004) , in this study we examined the DDX3Y protein expression throughout normal development, starting from early fetal stage. To shed some light on a possible role of DDX3Y in germ cell malignancy, we investigated its expression in CIS and various types of TGCT, including classical seminoma, spermatocytic seminoma and non-seminoma.
Materials and Methods

Human tissue samples
The use of human tissue samples in this project was approved by the Regional Committee for Medical Research Ethics in Denmark and the local ethics commission of the University of Heidelberg. Fetal and pre-pubertal tissue sections obtained from the archives of pathology department in Copenhagen were from legal abortions or still-born fetuses, while prepubertal samples were from autopsies. Most of this material was previously used in other studies Sonne et al., 2006) . In this study, we used 10 specimens of fetal testes ranging in age from 14 to 33 weeks of gestation (gw), 5 samples of post-natal pre-pubertal testes from 2 to 10 years of age and an adult testis sample displaying normal complete spermatogenesis as a positive control. Fresh frozen fetal, prepubertal and adult testis and ovary tissues were obtained from legal abortions and from clinically indicated gonadectomies, respectively. Other tissue samples (fetal male brain, kidney, liver and female ovary) were purchased commercially (Biocat GmbH; Heidelberg, Germany).
Tissue specimens with TGCTs were all obtained in Copenhagen (Rigshospitalet) directly after orchidectomy and macroscopic pathological evaluation. They were excised from overt tumours and from the surrounding macroscopically normal tissue, where tubules with CIS cells are commonly found. The tissue fragments were either snap frozen or fixed overnight at 48C in modified Stieve's fixative [200 ml formaldehyde (37%), 40 ml acetic acid (100%) add to 1000 ml total volume with 50 mM PBS buffer, pH 7.4], buffered formalin, paraformaldehyde or Bouin's fluid, and subsequently embedded in paraffin. Tissue sections were stained with haematoxylin and eosin for histological evaluation, and those with germ cell neoplasms were stained for placental-like alkaline phosphatase, a commonly used marker for CIS and seminoma (Giwercman et al., 1991) . For this study, we used in total 14 samples of CIS, 9 classical seminomas and 20 non-seminomas with variable histology, ranging from undifferentiated embryonal carcinoma (n ¼ 11) to fully differentiated mature teratomas (n ¼ 9) and 4 spermatocytic seminomas.
Immunoblotting
Total proteins were extracted from frozen-tissue specimens using standard protocols and resolved according to size on 12% SDS-polyacrylamide gels. Subsequently, the proteins were electrophoretically transferred from the gel onto Immobilon-P membrane (Millipore, Eschborn, Germany). After pre-incubation of the membrane in blocking solution [5% skimmed milk powder (Roth, Karlsruhe, Germany)] in 1× TNT (50 mM Tris, 150 mM NaCl, 5 mM EDTA and 0.05% Tween 20), pH 7.6 for 30 min at room temperature, it was incubated overnight at 48C with the polyclonal DBY-10 rabbit antiserum (1:500 v/v) recognizing only the DDX3Y protein (Ditton et al., 2004) . To control for sample loading of each lane, the blot was also incubated with a polyclonal antiserum (1:2000 v/v) against the ubiquitously expressed glyceraldehyde-3-phosphate dehydrogenase (GAPDH, FL-335: sc-25778; Santa Cruz Biotechnology, Inc., USA) overnight at 48C. An anti-rabbit IgG peroxidase conjugate (1:30000 v/v) was used as a secondary antibody (Dianova, Hamburg, Germany) in the same blocking solution for 1 h and visualization of the bound antibody was done using the Visualizer TM western blot detection kit (Millipore, Eschborn, Germany) for DDX3Y detection and the ECL Western Lightning chemiluminescence reagent plus kit (Perkin Elmer, Rodgau, Germany) for GAPDH detection.
Immunohistochemistry
Tissue biopsies were fixed in buffered formaldehyde or buffered Bouin's fixative or Stieve's fluid and subsequently embedded in paraffin. Sections, 5-mm thick, were dewaxed and rehydrated in decreasing concentrations of ethanol. Immunohistochemical staining was carried out with a standard indirect peroxidase method. Briefly, slides were pretreated with 5% (v/v) urea in a microwave oven, or with 0.1 M boric acid pH 7 at 608C overnight. Endogenous peroxidase was quenched by incubation in 0.5% hydrogen peroxide and unspecific binding was blocked with 3% (v/v) goat serum (DAKO, Glostrup, Denmark). All sections were incubated overnight at 48C with (1:600 v/v) DBY-10 antiserum. Subsequently, a secondary, biotinylated goat-anti-rabbit antiserum (DAKO, Glostrup, Denmark) was applied (1:100 v/v) followed by incubation with avidin-biotin complex (Zymed, San Francisco, CA, USA). Finally, slides were stained with 3,3
′ -diamino-benzidine tetrahydrochloride or aminoethyl carbazole (Zymed, San Francisco, CA, USA), counterstained with haematoxylin and mounted in Immuno-Mount (Shadon, Pittsburgh, PA, USA).
To confirm DDX3Y specificity of the DBY-10 immunostaining results, the same experiments were performed with the rabbit pre-immune serum (1:600 v/v) which produced the DBY-10 antiserum, or by incubating without the primary antibody (negative control; for details see Ditton et al., 2004) . As a positive control, the tissue section of a human adult testis displaying tubules with complete spermatogenesis was incubated with the same DBY-10 antiserum and pre-immune serum, respectively, and run in parallel with each experiment. An example of a positive control is shown in Fig. 3F .
Stained tissue sections of TGCTs were examined under the light microscope and scored systematically by three investigators (B.G., S.B.S., E.R.D.M.). The staining was assessed using an arbitrary score of the cells with '+++', when nearly all cells were stained; with '++' when approximately half of the cells were stained; with '+', when only a low percentage of scattered cells were stained; with '+/2' when a low number of cells were only stained in small tissue areas and with '2', when no stained cells were detected.
Recognition of germ cell maturation stages
The fetal germ cell types were recognized as gonocytes if they expressed OCT4 in sections cut in series to those stained for DDX3Y. The later maturation stages were recognized using the morphology-based classification of fetal spermatogonia described in the literature (Wartenberg, 1976 (Wartenberg, , 1989 Hilscher and Engemann, 1992; Gaskell et al., 2004) . The germ cells with a dark karyoplasm and little cytoplasm are the mitotically active M prospermatogonia, whereas the germ cells with light karyoplasm and sometimes a prominent nucleolus are the T1 prospermatogonia (non-dividing/resting). Around the 25th gw T2 prospermatogonia appear and these cells are recognized by their larger size and round large nucleus (Gaskell et al., 2004) .
In post-natal juvenile testes, two main subtypes of spermatogonia were recognized: A pale (Ap) and A dark (Ad; Clermont, 1966; Paniagua and Nistal, 1984) . Ad spermatogonia are distinguished by a dark ovoid nucleus often with an hallow, whereas Ap spermatogonia had lighter karyoplasms and rounder nuclei. B spermatogonia, which are rare in early childhood and appear closer to puberty, were recognized as smaller and rounder cells, with somewhat denser chromatin in the nuclei than the A-type.
Results
DDX3Y protein is only expressed in testis tissue during human development
We first addressed the question whether DDX3Y protein of expected size is expressed specifically in testis tissue during human development. For this purpose, western blot analysis was performed with proteins extracted from human male tissues of different age, including testis. A female tissue sample from fetal, juvenile and adult ovary was included as a negative control to confirm specificity of the used DBY-10 antiserum; it should not cross-react with the homologous DDX3X protein expressed in the ovary (Ditton et al., 2004) . We confirmed the testis tissue-specific expression of DDX3Y in human adult as first described by Ditton et al. (2004) and found a similar testis-specific expression of the DDX3Y protein also in the juvenile and fetal tissue samples (Fig. 1A) . The presence of a similar protein amount in each lane of the western blot is demonstrated by incubation with an antiserum against the ubiquitous expressed GAPDH protein (Fig. 1B) . Very weak DDX3Y expression was detected in the adult kidney tissue, and some DDX3Y protein variants of higher molecular weight were present at low intensity in prepubertal testis tissue. These results indicate that the prominent testis-specific DDX3Y expression in human tissues is already established during fetal development.
DDX3Y protein is expressed in fetal and prepubertal spermatogonia
To establish the cellular localization of DDX3Y proteins in the male germline, we performed immunohistochemical staining experiments Figure 1 DDX3Y and GAPDH protein expression in adult, juvenile and fetal human male tissue samples. Strong expression of DDX3Y (MW ¼ 73 kDa) was only found in the testis tissue samples (A), whereas GAPDH expression (MW ¼ 37 kDa) was found in each tissue analysed (positive control) (B). No DBY-10 cross-reaction to the female ovary samples confirmed DDX3Y specificity of the antibodies (negative control). Weak DDX3Y expression was found in the adult kidney sample; in prepubertal testis tissue some DDX3Y protein variants of increased molecular weight are indicated. No further cross-reacting protein bands were observed with both antisera below or above the western blot sections displayed in this figure.
DDX3Y expression in male germ cells with the DDX3Y-specific antiserum (DBY-10) on human fetal and prepubertal testis tissue sections of different developmental stages. We found no DDX3Y protein expression in any cell type at the 14th and 16th gw. The first significant expression was found at the 17th gw and exclusively in germ cells (Fig. 2) . In M and T1 prospermatogonia, DDX3Y protein was mainly found in the nuclei, whereas in T2 prospermatogonia DDX3Y was present mainly in the cytoplasm. No immunohistochemical staining pattern was observed when incubating the same series with the rabbit pre-immune serum used for DBY-10 production (see example in insert Fig. 2C ) The DDX3Y expression phase in M nuclei suggests a nuclear function because it corresponds to the phase of a high proliferation rate of these germ cells during fetal development (17 -22 gw; Hilscher and Engemann, 1992; Honecker et al., 2004) . Additional DDX3Y expression in the cytoplasm of T1 and T2 germ cells at the 25th and 33th gw suggests some function of DDX3Y in the translation control of unknown germ cell transcripts at later fetal germ cell development.
In juvenile testis samples from two boys at the age of 2 and 4.5 years, nuclear DDX3Y staining was seen first only in single Ap spermatogonia (2 years), then in a greater number of Ap spermatogonia (4.5 years) but not in Ad spermatogonia (Fig. 3A and B) . In specimens from boys between 6 and 10 years, DDX3Y was expressed either in the cytoplasm or nuclei of Ap and B spermatogonia; Ad spermatogonia were again not stained ( Fig. 3C -E) . In the testis tissue specimen of an adult man, we found strong nuclear and cytoplasmic DDX3Y expression in Ap spermatogonia and Ad spermatogonia (Fig. 3F) . Similar results were obtained when using the DDX3Y/DDX3X double-specific antiserum, DBXY-20, described by Ditton et al. (2004) . No staining was observed in control sections incubated with the rabbit pre-immune serum (see insert in Fig. 3E ). These results demonstrated that also in prepubertal testes DDX3Y protein is only expressed in germ cells; initially only in the nuclei of the proliferating Ap spermatogonia (2 -6 years), then also in the cytoplasm of Ap and B spermatogonia, but not in Ad spermatogonia until puberty.
DDX3Y expression in CIS/ITGCNU cells and in overt TGCT is present exclusively in germ cells
We subsequently investigated the expression of DDX3Y in preinvasive CIS/ITGCNU cells from tissues adjacent to TGCT specimens. We found strong DDX3Y expression in CIS cells in all 14 specimens studied (Fig. 4A) . The cellular DDX3Y distribution was similar to that found in fetal germ cells; being predominantly in the nuclei, and only occasionally in the cytoplasm, but in a small subset of cells both compartments were stained. No significant staining pattern was observed in serial tissue sections when incubated with the rabbit pre-immune serum (negative control).
We then examined the expression of DDX3Y in overt TGCT samples, including those derived from CIS (classical seminoma and non-seminoma), and spermatocytic seminoma derived from postpubertal spermatogonia. The tumours showed a variable number of DDX3Y-expressing cells. In classical seminomas, the largest proportion of positive cells was observed (Fig. 4B ), but staining intensity was usually weaker than in CIS cells. Some seminoma specimens were nearly DDX3Y negative; just a few positive cells scattered in the tissue were observed (data not shown). In non-seminomas we usually noted the absence of DDX3Y expression in embryonal carcinoma and in teratoma cells and only found local staining mainly in the nuclei in a few specimens (Table I) . This is consistent with the germ cell-specific role of DDX3Y. In tissue sections with spermatocytic seminoma, DDX3Y expression was usually found in a significant but variable number of cells and mainly in nuclei (Fig. 4C) . No reaction was found in the negative control sections. The DDX3Y expression data for TGCTs are summarized in Table I . 
DDX3Y expression in male germ cells
Discussion
In this paper we show that during human development DDX3Y is expressed only in male germ cells. The expression pattern suggests some involvement in the nuclear mechanism(s) controlling the germ cell proliferation waves during fetal development and before puberty. Before birth these are marked by the occurrence of the M prospermatogonia; after birth Ap spermatogonia are believed to be the single germ cell type having the functional capacity of selfpropagation (Ehmcke and Schlatt, 2006) . Accordingly, we found strong expression of DDX3Y in fetal M prospermatogonia and after birth in Ap spermatogonia but not in Ad spermatogonia.
A shift in DDX3Y expression from the nuclear to the cytoplasmic cell compartment around the age of 6 years ( Fig. 3C) suggests a new function during this phase of prepubertal development. It is likely mediated by direct cellular contacts with the maturing Sertoli cells and pertubular myoid cells. They express distinct paracrine factors released differentially during germ cell maturation (Wartenberg, 1989; Russel, 1993) . We hypothesise that at this stage of development, DDX3Y may contribute to the translation control of still unknown downstream transcripts, similarly to that described for its functional homologue DDX3X in somatic cells (Chuang et al., 1997; Schroeder, 2010) . At puberty, after the onset of adult spermatogenesis, this function likely intensifies, as demonstrated by the presence of the DDX3Y protein now mainly in the cytoplasm, not only of Ap, but also of Ad, spermatogonia (Fig. 3F) . Obviously, the DDX3Y protein can shuttle in male germ cells between the nuclear and cytoplasmic compartment similarly as is known for the somatic DDX3X protein (Schroeder, 2010) .
We thus postulate that DDX3Y protein is necessary for male germ cell amplification and survival already before puberty. If this holds true, the azoospermia and Sertoli-cell-only syndrome observed in infertile men with AZFa deletions that encompass the DDX3Y gene (Foresta et al., 2000; Kamp et al., 2001 ) may have its roots in germ cell depletion occurring already during fetal or pre-pubertal development.
DDX3Y protein expression was not found in fetal gonocytes at the 14th and 16th gws. For ethical reasons it was impossible to get earlier fetal human tissue samples. We can therefore not yet exclude an earlier expression of DDX3Y in primordial germ cells, before the colonization of the fetal gonads occurring around the 7th gw (Wartenberg, 1989) .
The lack of DDX3Y in early gonocytes but its strong expression in CIS cells, which are considered to be transformed gonocytes (Sonne et al. 2009) Spermatocytic seminoma 4 + CIS, carcinoma in situ. The proportion of DBY-10 positively stained cells was assessed using an arbitrary score (as described in the Materials and Methods section). All TGCT specimens were isolated from the testis tissue of adult men.
CIS cells (Aubry et al., 2001; Gaskell et al., 2004) and Chk2 detected in nearly all CIS cells (Bartkova et al., 2001 ). Similar to DDX3Y, both MAGE-A4 and Chk2 first appear in fetal germ cells around the 17th gw, consistent with the expression in fetal prospermatogonia but not in gonocytes. Alternatively, CIS cells may originate from DDX3Y-negative fetal gonocytes but then progress along their differentiation from a 'dormant' to a proliferating 'high-grade' CIS cell after becoming exposed to a distinct microenvironment of the testis at later stages of development. A similar cellular progression was recently described for breast CIS cells (Laenkholm et al., 2008) . It is therefore conceivable that CIS cells, known for their relative genomic instability and phenotypic plasticity (Rajpert-De Meyts et al., 2003b) , are able to respond to cellular signals promoting rapid proliferation after puberty thereby up-regulating CIS cell DDX3Y expression.
Our data do not exclude the possibility that CIS cells might also derive from post-pubertal spermatogonia reverting back towards an embryonic phenotype, as shown recently in two ex situ cell culture systems (Conrad et al., 2008; Payne and Braun, 2008) . In this context, it is interesting to note that the germ cell-specific RBMY splicing factor is not expressed in CIS cells (Lifschitz-Mercer et al., 2000; Schreiber et al., 2003) . RBMY is known as a key factor for directing Ap spermatogonia towards their differentiation pathway and towards meiosis. It is involved in the nuclear metabolism of newly synthesized RNA in fetal, prepubertal and adult spermatogonia (for review : Elliott, 2004) . The lack of RBMY expression but high DDX3Y expression in the pluripotent CIS germ cells thus suggests that these TGCT precursor cells have lost the pathway of spermatogonia differentiation control.
The variable expression of DDX3Y in overt classical seminomas and the low or absent expression in non-seminomas (teratoma, embryonal carcinoma) is consistent with the male germ cell-specific function of this protein. The variable immunohistochemical DDX3Y-expression pattern therefore indicates the individual progression of the seminoma phenotype in these patients towards somatic differentiation of these tumour cells. However, expression of DDX3Y in these tumours may also become variable depending on the number of cells with a Y chromosome in their karyotype. TGCT patients with distinct mosaicism and aneuploidies of sex chromosomes are well known in the literature (Looijenga et al., 2000; Rajpert-De Meyts et al., 2007) . Using a combination of immunohistochemistry and FISH with a Y-specific probe would help here to establish whether or not the DDX3Y-negative tumour cells are also devoid of the Y chromosome.
In conclusion, this study provides the first description of the developmental expression of DDX3Y protein in human testis being consistently restricted to the germ cell. Germ-cell specific expression is also retained in the invasive TGCT. The lack of DDX3Y expression in fetal gonocytes but its up-regulation in CIS cells in adult testes suggests that full transformation of arrested gonocytes into the CIS phenotype may first occur in these germ cells after puberty. It indicates an inherent plasticity of these germ cells in responding to microenvironmental changes in the niche.
